These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 19250106)

  • 1. Prevention of venous thrombosis by warfarin after permanent transvenous leads implantation in high-risk patients.
    Costa R; Da Silva KR; Rached R; Martinelli Filho M; Carnevale FC; Moreira LF; Stolf NA
    Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S247-51. PubMed ID: 19250106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of venous obstruction following pacemaker or implantable cardioverter-defibrillator implantation: a contrast venographic study on 100 patients admitted for generator change, lead revision, or device upgrade.
    Haghjoo M; Nikoo MH; Fazelifar AF; Alizadeh A; Emkanjoo Z; Sadr-Ameli MA
    Europace; 2007 May; 9(5):328-32. PubMed ID: 17369270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between selected risk factors and the incidence of venous obstruction after pacemaker implantation: demographic and clinical factors.
    Lelakowski J; Domagała TB; Cieśla-Dul M; Rydlewska A; Majewski J; Piekarz J; Kotula-Horowitz K; Sadowski J
    Kardiol Pol; 2011; 69(10):1033-40. PubMed ID: 22006604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Warfarin prevents venous obstruction after cardiac devices implantation in high-risk patients: partial analysis.
    Silva KR; Costa R; Abi Rached R; Martinelli Filho M; Caldas JG; Carnevale FC; Moreira LF; Stolf NA
    Rev Bras Cir Cardiovasc; 2008; 23(4):542-9. PubMed ID: 19229428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators.
    Agnelli G; Prandoni P; Santamaria MG; Bagatella P; Iorio A; Bazzan M; Moia M; Guazzaloca G; Bertoldi A; Tomasi C; Scannapieco G; Ageno W;
    N Engl J Med; 2001 Jul; 345(3):165-9. PubMed ID: 11463010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism.
    Ridker PM; Goldhaber SZ; Danielson E; Rosenberg Y; Eby CS; Deitcher SR; Cushman M; Moll S; Kessler CM; Elliott CG; Paulson R; Wong T; Bauer KA; Schwartz BA; Miletich JP; Bounameaux H; Glynn RJ;
    N Engl J Med; 2003 Apr; 348(15):1425-34. PubMed ID: 12601075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and risk factors of early venous thrombosis associated with permanent pacemaker leads.
    van Rooden CJ; Molhoek SG; Rosendaal FR; Schalij MJ; Meinders AE; Huisman MV
    J Cardiovasc Electrophysiol; 2004 Nov; 15(11):1258-62. PubMed ID: 15574174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lead-induced venous thrombosis:consequences?
    Wilkoff BL
    J Cardiovasc Electrophysiol; 2004 Nov; 15(11):1263-4. PubMed ID: 15574175
    [No Abstract]   [Full Text] [Related]  

  • 9. Implantation of cardiac rhythm devices without interruption of oral anticoagulation compared with perioperative bridging with low-molecular weight heparin.
    Tischenko A; Gula LJ; Yee R; Klein GJ; Skanes AC; Krahn AD
    Am Heart J; 2009 Aug; 158(2):252-6. PubMed ID: 19619702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism.
    Kearon C; Gent M; Hirsh J; Weitz J; Kovacs MJ; Anderson DR; Turpie AG; Green D; Ginsberg JS; Wells P; MacKinnon B; Julian JA
    N Engl J Med; 1999 Mar; 340(12):901-7. PubMed ID: 10089183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and risk factors of upper extremity deep vein lesions after permanent transvenous pacemaker implant: a 6-month follow-up prospective study.
    Da Costa SS; Scalabrini Neto A; Costa R; Caldas JG; Martinelli Filho M
    Pacing Clin Electrophysiol; 2002 Sep; 25(9):1301-6. PubMed ID: 12380764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upper extremity deep venous thrombosis and stenosis after implantation of pacemakers and defibrillators; A prospective study.
    Safi M; Akbarzadeh MA; Azinfar A; Namazi MH; Khaheshi I
    Rom J Intern Med; 2017 Sep; 55(3):139-144. PubMed ID: 28432849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of cancer after prophylaxis with warfarin against recurrent venous thromboembolism. Duration of Anticoagulation Trial.
    Schulman S; Lindmarker P
    N Engl J Med; 2000 Jun; 342(26):1953-8. PubMed ID: 10874063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of selected prothrombotic and proinflammatory factors on the incidence of venous thrombosis after pacemaker implantation.
    Lelakowski J; Domagała TB; Rydlewska A; Januszek R; Kotula Horowitz K; Majewski J; Ząbek A; Małecka B; Musiał J
    Kardiol Pol; 2012; 70(3):260-7. PubMed ID: 22430407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Permanent pacemaker-related upper extremity deep vein thrombosis: a series of 20 cases.
    Mandal S; Pande A; Mandal D; Kumar A; Sarkar A; Kahali D; Mazumdar B; Panja M
    Pacing Clin Electrophysiol; 2012 Oct; 35(10):1194-8. PubMed ID: 22816726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The incidence and risk factors for venous obstruction after implantation of transvenous pacing leads.
    Oginosawa Y; Abe H; Nakashima Y
    Pacing Clin Electrophysiol; 2002 Nov; 25(11):1605-11. PubMed ID: 12494619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of hematoma complications after device implant in the clopidogrel era.
    Kutinsky IB; Jarandilla R; Jewett M; Haines DE
    Circ Arrhythm Electrophysiol; 2010 Aug; 3(4):312-8. PubMed ID: 20558847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression of venous pathology after pacemaker and cardioverter-defibrillator implantation: A prospective serial venographic study.
    Korkeila P; Ylitalo A; Koistinen J; Airaksinen KE
    Ann Med; 2009; 41(3):216-23. PubMed ID: 18979290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter-defibrillators: results of a large, prospective, randomized, double-blinded, placebo-controlled trial.
    de Oliveira JC; Martinelli M; Nishioka SA; Varejão T; Uipe D; Pedrosa AA; Costa R; D'Avila A; Danik SB
    Circ Arrhythm Electrophysiol; 2009 Feb; 2(1):29-34. PubMed ID: 19808441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation.
    Hull R; Raskob G; Pineo G; Rosenbloom D; Evans W; Mallory T; Anquist K; Smith F; Hughes G; Green D
    N Engl J Med; 1993 Nov; 329(19):1370-6. PubMed ID: 8413432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.